pharma · Parkinson's Disease · PARKINSON DISEASE (Disorder) · SER
Serina Therapeutics
Serina Therapeutics is a pharma organization headquartered in Huntsville, USA. It trades on NYSE under ticker SER. Primary therapeutic focus areas include Parkinson's Disease, PARKINSON DISEASE (Disorder). NovaPharmaNews
Huntsville, USA HQ
2007 Founded
23 Employees
Public company Type
SER · NYSE Ticker
Company details
- Status
- Public
- HQ
- Huntsville, USA
- Founded
- 2007
- Employees
- 23
- Programs
- 2
- Drugs
- 3
- Patents
- 25
SER-252 (PEOZ-apomorphine)
Phase 1 · small molecule · PARKINSON DISEASE (Disorder)
SER-252 (PEOZ-apomorphine) for PARKINSON DISEASE (Disorder) is a Phase 1 program (small_molecule) at Serina Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code SER-252-1b
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Serina Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- PARKINSON DISEASE (Disorder)
- Status
- active
- Trials
- 1